Taipei Times: What is the life-saving potential of an HIV vaccine?
David Ho (
PHOTO: SU MENG-CHUAN, TAIPEI TIMESN
TT: From a clinical perspective, is there any possibility that we can produce large doses of vaccines in a cheap way?
Ho: Yes, I think most vaccines we and other people are working on are not very expensive. They will be more affordable than drugs. Many people who are working on the vaccines are doing it not because of profit. We are doing science and we want to make a contribution. If we have a vaccine that works, we don't intend to make a profit.
TT: How do your two vaccines, the DNA and MVA vaccines, work to prevent AIDS?
Ho: The DNA vaccine is composed of two plasmids that can express five HIV genes. This kind of multivalent vaccine will enhance the immune system's ability to detect the rapidly changing HIV virus and trigger a cell-mediated immune response to protect the body. The second vaccine under research is the MVA vaccine. We used a specific strain of modified vaccinia called Ankara, and inserted the same set of five HIV genes as in the DNA vaccine.
TT: How do these two vaccine developments progress? Can you describe the design of the clinical trials you have been conducting?
Ho: Our trials are still very premature. Trials are in Phase I, II, and III. Phase I is primary. The first trial is to make sure the product is safe. We have been doing the DNA vaccine for about a year. This month, we conducted a human clinical trial involving 45 subjects from New York City, and so far it seems to be safe. We'd like to move on to Phase II to test the immune response in people who received the vaccine. We have been working on the second one, the MVA vaccine, for four years. It's very close to beginning the Phase I study. We think it [Phase I human clinical trial] will come in the next few weeks. We are very excited to be able to take two products all the way from the lab to the clinic in four years' time.
TT: Your DNA vaccine candidate has gained approval from the US' FDA (Food and Drug Administration), yet another MVA vaccine hasn't. When do you think the permission will come?
Ho: We expect the second one very soon. In fact, we expect the approval to come any day. Hopefully, by January next year we could do the Phase I trial with the MVA vaccine.
TT: In your speech on Thursday (Dec. 16), you mentioned that you used similar platform technology to develop a SARS vaccine. Can you briefly talk about the mechanics and effect of the SARS vaccine?
Ho: We develop a SARS vaccine using vaccinia, like the MVA vaccine. So far, it's worked quite well in Chinese macaques. We are able to raise antibodies that could block the infection of the SARS virus in the laboratory. Then we put these [antibodies] into monkeys. All vaccinated monkeys are protected from infection. It's a very promising outcome.
TT: You noted that the AIDS is difficult to treat because of the HIV's mysterious ability to mutate. Do you notice any similar property in SARS coronavirus?
Ho: The SARS coronavirus will also change. Many of the so-called RNA viruses make mutations when they divide and replicate. But what is different is that SARS virus only replicates for a few weeks, whereas HIV virus replicates for years and years. This is why you [HIV vaccine developers] keep making mistakes and changes. Since SARS only allows the virus to replicate for a short amount of time, it probably won't change as fast as HIV.
TT: The SARS vaccine is now proven to be safe and effective in the monkey trial you conducted with the Chinese Academy of Medical Science. What will be the next step and what are the challenges?
Ho: We now need to figure out how to bring this to testing in people. The clinical trial part will be very difficult. You have to come up with the funding to make a [vaccine] product. You also need funds to support the clinical trial. All these things cost a fair amount of money, ranging from US$5 million to US$10 million. The problem is -- who is going to invest in them when there is no SARS right now?
TT: Do you think Taiwan is equipped with the technology to conduct the clinical trial and develop the SARS vaccine?
Ho: Yes, I think if Taiwan pools the right people and groups together, it could make the vaccine. Once again, the difficult part to determine is who -- the private sector or the government -- is going to make an investment. I don't see the private sector gambling with their money. It is almost the government's responsibility to invest in the vaccine research and development process. It's a question of political will. So that when the next SARS epidemic comes, whenever it is, you are at least prepared with vaccines.
TT: Compared to Hong Kong, Singapore, China and other Asian countries, do you think Taiwan is a preferable place to develop a SARS vaccine?
Ho: Comparing Taiwan, Hong Kong, and Singapore, I think Taiwan is just as good as any of them. Taiwan is probably better than Hong Kong in terms of environment. Singapore is very focused and trying to do something, too.
TT: Is there a possibility that you will work together with a certain regional government?
Ho: We want to cooperate with any government -- whoever wants to develop the vaccine.
TT: What are future challenges facing scientists in the HIV vaccine and SARS vaccine research areas?
Ho: I think HIV is going to be very tough. The vaccine still has a long road ahead. It will take years and years to determine whether these vaccines work. The HIV effort will be a struggle for the next 10 years. But in the case of SARS, all the data and results suggest that we should be able to protect ourselves against the virus. I am much more optimistic about the SARS vaccine, should there be enough investment to allow some of the vaccine candidates to be developed and tested. I am hopeful for an effective SARS vaccine.
A group of Taiwanese-American and Tibetan-American students at Harvard University on Saturday disrupted Chinese Ambassador to the US Xie Feng’s (謝鋒) speech at the school, accusing him of being responsible for numerous human rights violations. Four students — two Taiwanese Americans and two from Tibet — held up banners inside a conference hall where Xie was delivering a speech at the opening ceremony of the Harvard Kennedy School China Conference 2024. In a video clip provided by the Coalition of Students Resisting the CCP (Chinese Communist Party), Taiwanese-American Cosette Wu (吳亭樺) and Tibetan-American Tsering Yangchen are seen holding banners that together read:
UNAWARE: Many people sit for long hours every day and eat unhealthy foods, putting them at greater risk of developing one of the ‘three highs,’ an expert said More than 30 percent of adults aged 40 or older who underwent a government-funded health exam were unaware they had at least one of the “three highs” — high blood pressure, high blood lipids or high blood sugar, the Health Promotion Administration (HPA) said yesterday. Among adults aged 40 or older who said they did not have any of the “three highs” before taking the health exam, more than 30 percent were found to have at least one of them, Adult Preventive Health Examination Service data from 2022 showed. People with long-term medical conditions such as hypertension or diabetes usually do not
POLICE INVESTIGATING: A man said he quit his job as a nurse at Taipei Tzu Chi Hospital as he had been ‘disgusted’ by the behavior of his colleagues A man yesterday morning wrote online that he had witnessed nurses taking photographs and touching anesthetized patients inappropriately in Taipei Tzu Chi Hospital’s operating theaters. The man surnamed Huang (黃) wrote on the Professional Technology Temple bulletin board that during his six-month stint as a nurse at the hospital, he had seen nurses taking pictures of patients, including of their private parts, after they were anesthetized. Some nurses had also touched patients inappropriately and children were among those photographed, he said. Huang said this “disgusted” him “so much” that “he felt the need to reveal these unethical acts in the operating theater
Heat advisories were in effect for nine administrative regions yesterday afternoon as warm southwesterly winds pushed temperatures above 38°C in parts of southern Taiwan, the Central Weather Administration (CWA) said. As of 3:30pm yesterday, Tainan’s Yujing District (玉井) had recorded the day’s highest temperature of 39.7°C, though the measurement will not be included in Taiwan’s official heat records since Yujing is an automatic rather than manually operated weather station, the CWA said. Highs recorded in other areas were 38.7°C in Kaohsiung’s Neimen District (內門), 38.2°C in Chiayi City and 38.1°C in Pingtung’s Sandimen Township (三地門), CWA data showed. The spell of scorching